Background-As coronary perforation (CP) is a rare but serious complication of percutaneous coronary intervention (PCI) the current evidence base is limited to small series. Using a national PCI database, the incidence, predictors, and outcomes of CP as a complication of PCI were defined. Adjusted odds of adverse outcomes were higher in patients with CP for all major adverse coronary events, including stroke, bleeding, and mortality. Emergency surgery was required in 3% of cases. Predictors of mortality in patients with CP included age, diabetes mellitus, previous myocardial infarction, renal disease, ventilatory support, use of circulatory support, glycoprotein inhibitor use, and stent type. Conclusions-Using a national PCI database for the first time, the incidence, predictors, and outcomes of CP were defined.
C oronary perforation (CP) is a rare but serious complication of percutaneous coronary intervention (PCI) with an estimated incidence of ≈0.5%. 1 Entry of arterial blood into the pericardial space can lead to rapid elevation of the pericardial pressure and rapid hemodynamic compromise. Historically, urgent surgical drainage was a standard treatment, but the development of new technologies such as covered stents and embolization coils and new techniques such as thrombus and fat injection have allowed many perforations to be treated in the catheterisation laboratory without the need for surgical intervention. 2, 3 However, despite improvements in interventional skills and equipment, PCIs are increasingly complex with a higher prevalence of multivessel disease, worsening comorbidities (such as increasing age and renal dysfunction), and increasingly complex procedures including the treatment of chronic total occlusions (CTO). In light of these temporal changes, it is likely that CPs will continue to occur.
Although there are several published series of CP, the rarity of the complication has limited the literature to small series derived from single-center experience. The largest published series describes 124 events, and the total literature is <1000 cases. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Given the small numbers of events per published series, it has not been possible to examine several key questions relating to the occurrence and outcomes of CP. First, it is unclear from the available evidence what the true incidence of CP is and whether its incidence increasing or decreasing. Second, because of the size of the published series, it is not been possible to define exactly which demographic and procedural factors are predictive of CP. Finally, the treatment and outcomes of CP are not clearly defined.
Therefore, the objectives of the present study were to overcome these limitations, and use for the first time a national PCI database to define the true incidence of CP during PCI, to describe which factors are predictive of CP, and to define the outcomes after CP.
Methods Study Design, Setting, and Participants
We retrospectively analyzed prospectively collected national data from all patients who underwent PCI in England and Wales between January 2006 and December 2013.
Setting, Data Source, and Study Size
Data on PCI practice in the United Kingdom were obtained from the British Cardiovascular Intervention Society (BCIS) data set that records this information prospectively and publishes this information in the public domain as a part of the national transparency agenda. 21 The overall data collection process is overseen The National Institute of Cardiovascular Outcomes Research (http://www.ucl.ac.uk/nicor/), and in 2013, 98.6% of all PCI procedures performed in the National Health Service hospitals in England and Wales (www.bcis. org.uk/) were recorded on the database. The BCIS-National Institute of Cardiovascular Outcomes Research database contains 113 clinical, procedural, and outcomes variables with ≈80 000 new records added each year. [22] [23] [24] The participants of the database are tracked by the Medical Research Information Services for subsequent mortality using the patients' National Health Service number (a unique identifier for any person registered within the National Health Service in England and Wales).
Study Definitions
We analyzed all recorded PCI procedures that were undertaken in the England and Wales between January 1, 2006, and December 31, 2013. Patients were categorized according to whether they sustained a CP during the PCI procedure. In the BCIS data set, the definition of CP is left to the discretion of the operators. The outcomes examined were in-hospital major adverse cardiac events (MACE) (a composite of in-hospital mortality and in-hospital myocardial infarction or reinfarction and target vessel revascularization), 30-day mortality, 1-year mortality, 5-year mortality, in-hospital reinfarction, in-hospital emergency coronary artery bypass graft (CABG), in-hospital cardiac tamponade, in-hospital stroke, and in-hospital major bleeding (defined as gastrointestinal bleed, intracerebral bleed, retroperitoneal hematoma, blood or platelet transfusion, or an arterial access site complication requiring surgery). Participants with missing information on CP, age, or sex were excluded. A detailed account of the participant inclusion process is shown in Figure 1 .
Data Analyses
Statistical analysis was performed using Stata v13.1 (College Station, TX). Multiple imputations using the mi impute command were used to reduce the potential bias from missing data, assuming missing at random mechanisms. We used chained equations to impute the data for all variables with missing information and generated 10 data sets to be used the analyses.
We examined the baseline characteristics of participants by CP status. These variables included age, sex, smoking status, body mass index, family history of coronary heart disease, hypertension, hyperlipidaemia, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous CABG, left ventricular function, cardiogenic shock, circulatory support, mechanical ventilation, antiplatelet therapy, warfarin use, bivalirudin use, glycoprotein IIb/IIIa inhibitors use, vessel attempted for PCI (vein graft, left main, left anterior descending, circumflex, and right coronary), postprocedural TIMI (Thrombolysis in Myocardial Infarction) flow, radial access, stent implanted, rotational atherectomy use, laser angioplasty use, cutting balloon use, presence of a chronic occlusion, surgical cover, year of PCI, and indication (stable angina, non-ST-segment-elevation myocardial infarction, and ST-segment-elevation myocardial infarction). Descriptive measures for all these variables were calculated over time. We tested for associations between each categorical variable and CP using a χ 2 test, and for continuous variables we used 1-way ANOVA. In addition, the rates of CP by year of PCI are presented. The outcomes of interest were 30-day mortality, 1-year mortality, 5-year mortality, in-hospital bleeding, reinfarction, emergency CABG, stroke, cardiac tamponade, side branch occlusion, and coronary dissection for which we initially calculated the crude rates by CP status. To obtain adjusted measures of the associations between CP and the outcomes, we used logistic regressions. In the first set of models, we used multiple logistic regression and included all potential predictors as covariates, to quantify the independent association between perforation and outcomes. In a second set of models, we used the potential predictors to calculate a propensity score on perforation and weighted simple logistic regressions, of perforation on outcomes, on the inverse of the score (inverse probability treatment weighting). A third set of simple regressions used the propensity score to perform matching with replacement to control for the effect of the covariates and estimate the average treatment effect of CP on outcomes (teffects psmatch in Stata). The average treatment effect is the mean difference in the outcome between patients with perforation and those without. The covariates included in the models were as follows: age, sex, smoking status, body mass index, family history of coronary artery disease, hypercholesterolaemia, hypertension, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous CABG, left ventricular function, cardiogenic
WhAT IS KNOWN
• Coronary perforation is a rare event, and there are little data about the predictors, outcomes, and temporal trends of coronary perforation after percutaneous coronary intervention.
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• In a national database, the incidence of coronary perforation was 0.3%.
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shock, ventilator use, circulatory support, antiplatelet therapy, warfarin, glycoprotein IIb/IIIa inhibitor, bivalirudin use, radial access, surgical cover, year, vessel of PCI, chronic occlusion, postprocedure TIMI flow, stent type used, rotational atherectomy, laser angioplasty, cutting balloon, side branch occlusion, coronary dissection, and diagnosis. The success of the propensity score matching was investigated by calculating descriptive statistics of the propensity score in each group and its absolute difference within each matched pair (balance diagnostics). An additional sensitivity analysis was performed by performing multiple logistic regressions with and without adjustments for center volume.
Results

Incidence and Baseline Demographics by Perforation Status
Between 2006 and 2013, 1762 CPs were recorded from 527 121 PCI procedures giving an overall incidence of 0.33%. The crude numbers of CP increased year on year (Figure 2 ), reflecting an increase in the total PCI volume in the United Kingdom during the study period. However, the annual incidence varied from 0.29% to 0.36% with a trend upward that did not reach statistical significance (P=0.359). The baseline demographics for patients with and without CP are presented in Table 1 . Patients with CP were more often women or older, with a greater burden of comorbidity including hypertension, hypercholesterolemia, previous myocardial infarction, peripheral vascular disease, and left ventricular dysfunction. Importantly, when considering consent for procedures, CP was more likely to occur in stable angina PCI.
Procedural Variables by Perforation Status
The procedural variables for patients with and without CP are presented in Table 2 . Perforation was associated with the use of glycoprotein IIb/IIIa inhibitor, left main disease, circumflex disease, and right coronary disease, postprocedure TIMI flow, type of stent implanted, rotational atherectomy, laser angioplasty, and chronic occlusion.
Using multivariate analyses covariates found to be associated with CP were identified and are presented in Table 3 . Factors associated with an increased risk of perforation were age, hypercholesterolaemia, previous CABG, left main intervention, CTO intervention, use of rotational atherectomy, procedural dissection, side-branch occlusion, and non-STsegment-elevation myocardial infarction diagnosis. Factors associated with a decreased risk of perforation were male sex, diabetes mellitus, presentation with shock, and use of a cutting balloon.
Clinical Outcomes by Perforation Status
Clinical and procedural complications and adverse outcomes recorded in the BCIS database were more frequent in patients with CP (Table 4 ). In-hospital MACE was significantly higher in those patients with CP than in those without (26% versus 2%; P<0.001), as was 30-day, 1-year, and 5-year mortality. The 30-day mortality after perforation varied from 6.6% to 15.5% with a significant upward trend (P=0.049) that was also significant for 1-year mortality (P<0.001). We observed similar significant increase in mortality at both 30 days and 1 year for the group that did not sustain CP over time ( Table I in the Data Supplement). Overall, national PCI mortality with and without perforation by year is presented in Figure 3 . The characteristics of predictive factors for perforation over time are presented in Table II in the Data Supplement (means or percentages and respective confidence intervals) and indicate a significant increase in the mean complexity of the cases experiencing perforation (including patient age, presentation with shock, diabetes mellitus, history of CABG, and left main PCI). Noncoronary end points including in-hospital major bleeding and stroke were also significantly more frequent. In patients with CP, tamponade occurred in 14% of cases with 3% of patients required emergency reparative surgery. Using multiple logistic regression analyses and inverse probability-weighting propensity scoring, the adjusted odds of clinical outcomes are presented in Table 5 . The predictors of 30-day mortality in patients with a CP are presented in Table 6 and included increasing age, previous diabetes mellitus, previous myocardial infarction, renal disease, use of ventilatory support, use of circulatory support, glycoprotein IIb/IIIa inhibitor use, and stent type. The results of the propensity score matching analysis on 10 imputed data sets using average treatment effects are demonstrated in Table III in the Data Supplement. There were significant increases in in-hospital MACE, 30-day mortality, 1-year mortality, in-hospital cardiac tamponade, and in-hospital bleeding with CP after propensity score matching. The balance diagnostics of the propensity score matching are shown in Table IV in the Data Supplement. In considering the effect of center volume on outcomes, the overall median and interquartile range of center volume was 1295 (617-1771) procedures/y. The respective center volume results for patients who had CPs was lower 1189 (599-1771) procedures/y. Sensitivity analysis considering the effect of an additional adjustment for center volume did not significantly alter the results in the absence of this adjustment (Table V in the Data Supplement).
Discussion
The current study is the first analysis of CP as a complication of PCI performed from a national angioplasty database. Although there are several previously published series, their small size has limited the robustness of any conclusions and in particular multiple logistic regression analyses of the predictors of CP and predictors of mortality in those who experience perforation have not been performed before because of small sample sizes. The incidence of CP during PCI in the current study is consistent with that reported in the previous smaller studies and is midway between the lowest reported frequency of 0.12% and the upper reported frequency of 0.82%. 10, 11 Two summary studies have reported on the occurrence of CP. The 16 published CP studies involving 197 061 PCIs were summarized recently. In this largely descriptive article, the perforation frequency was 0.43% although no additional analyses were presented. 1 In the second summary analysis, Patel et al 25 reported 419 perforations from 65 studies of 18 061 patients undergoing CTO PCI. In this series, the reported frequency of CP was 2.9% with a tamponade frequency of 0.2%. Although this is a large series of CP, no further data were presented on the perforation subset of the main study. In the current study, a subanalysis of the annualized data demonstrates not only a year-on-year increase in the crude numbers of perforation as the number of UK PCIs increase but also a nonsignificant trend for the percentage frequency to increase. Given the independent predictors of perforation identified in this study, it is perhaps not surprising in view of the aging population with increasingly complex non-CTO and CTO procedures that the frequency of perforation is unlikely to drop. [26] [27] [28] Based on the current data, it would seem reasonable to predict that the frequency of CP might actually increase in coming years.
Several previous studies have examined the baseline and procedural factors associated with perforation although none have had the sample size to perform multiple logistic regression analyses. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The findings of these smaller studies have reported somewhat divergent findings although increasing age, use of rotational atherectomy, complex lesions, and CTO intervention all feature more commonly. The current study largely confirms the tentative findings of previous studies confirming women and the elderly to be at risk of CP and those cases in which atherectomy devices are utilized. Novel predictors of CP Potential predictors in the model: age, sex, smoking status, body mass index, family history of coronary artery disease, hypercholesterolaemia, hypertension, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous CABG, left ventricular function, cardiogenic shock, ventilator use, circulatory support, radial access, surgical cover, year, vessel of PCI, chronic occlusion, stent type used, rotational atherectomy, laser angioplasty, cutting balloon, sidebranch occlusion, coronary dissection and diagnosis. CABG indicates coronary artery bypass graft; CI, confidence interval; NSTEMI, non-ST-segment-elevation myocardial infarction; and PCI, percutaneous coronary intervention.
in the current study include patients with previous CABG, left main stem intervention, and a reduced frequency in diabetics and in cases with cutting balloon use. The observation that both BMS and DES use were associated with a lower likelihood of perforation may be explained by several factors including guidewire perforation, and the fact that the use of covered stent is not recorded as a separate field in the database. In addition, the occurrence of a perforation with predilation may lead operators to terminate the procedure after control of the perforation, without continuing to stent implantation. The observation that the use of a cutting balloon seemed to be protective against perforation is a novel finding and may support the hypothesis that careful lesion preparation thus necessitating less aggressive postdilatation could reduce the incidence of perforation. The multicenter nature of the database also allowed an analysis of the influence of on-site versus off-site cardiac surgical support, and no relationship was observed.
The incidence of major adverse events in patients with CP was high with a 13-fold increase in in-hospital MACE and a 5-fold increase in 30-day mortality. These data are a stark reminder that while CP during PCI is a relatively rare event, when it does occur the outcome remains extremely poor. In addition, we observed a significant increase in mortality at 30 days and 1 year in patients who had CP and patients who did not have CP. This may reflect an increase in undertaking PCI on higher risk patients with time. However, the magnitude of increase in mortality was higher in the CP group than in the nonperforation group that may also reflect the increased complexity of patients experiencing a perforation. Tamponade occurred in 14% of patients with CP, a finding that is testament to the skill of the operators necessitating rapid resuscitation, balloon occlusion, and placement of a pericardial drain to avoid its occurrence. The rate of surgical repair was also extremely low (3%) in the current series and likely reflects the development of interventional tools such as covered stents and embolization coils, as well as a wider appreciation of techniques such as distal fat and thrombus embolization to treat distal wire tip perforations.
2,3
The size of the current analysis also enabled a multiple logistic regression analysis of the predictors of an adverse outcome in those patients who experienced a CP. The results are largely intuitive with increasing age, previous myocardial infarction, and renal disease, all strongly predictive of increased mortality. The observed increased mortality associated with stent use may be explained by the lack of a dedicated covered stent field in the database, ie, the use of a covered stent may be recorded as no stent used. This analysis also supports the anecdotal experience that if a CP does occur, concomitant periprocedural use of a glycoprotein IIb/IIIa inhibitor is associated with worse outcomes, with an almost doubling of 30-day mortality. This analysis has several strengths. The BCIS data set includes >98% of all PCI procedures performed in the UK, which therefore reflects a national, real-world experience that includes high-risk patients encountered in daily interventional practice (who are often excluded from randomized controlled trials). Therefore, for the first time, the occurrence of perforation is reported on a national basis. Our analysis of over ½ million PCI procedures represents that largest analysis to date by several orders of magnitude, analyzing temporal trends, predictors and outcomes for the first time derived from >1700 perforations. Such large national registry data with unselected enrollment are important for evaluation of low-frequency complications such as CP, particularly given that such low event rates would mean that single-center registries/RCTs would be grossly underpowered.
Limitations
In addition, although the BCIS database does not specifically define perforation (leaving recording of this complication at the discretion of the operator), the observed incidence of perforation in our large series implies that reasonable clinical judgment was applied by UK operators. In addition, the BCIS database does not differentiate between CPs resulting from guidewire and perforations because of vessel rupture by balloon or stent inflation or provide data on perforation severity. Therefore, we are unable to provide separate analyses on the predictors and outcomes of these subgroups of CP or a substratification by perforation severity is not possible within the constraints of the current data set. The independent associations between covariates and a perforation complication that we have reported cannot infer causality, but may relate to changes in the procedure/clinical status occurring as a consequence of the perforation. For example, the use of circulatory support is associated with increased odds of perforation 4-fold, but this may not be a causal but merely reflect that post perforation, patients are more likely to require circulatory support because of significant hemodynamic compromise.
Similarly, side-branch occlusion may be associated with the use of a covered stent. Also, as the BCIS database only records emergency CABG as an outcome after CP. As a result, we are unable to provide data on the use of covered stents, pericardial drains, or embolization coils. Finally, census data were only available at specific time points with time to census data not available in the data extract that was used for this analysis. It has, however, been shown that for relatively short follow-up Potential predictors in the model: age, sex, smoking status, body mass index, family history of coronary artery disease, hypercholesterolaemia, hypertension, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous coronary artery bypass graft, left ventricular function, cardiogenic shock, ventilator use, circulatory support, antiplatelet therapy, warfarin, glycoprotein IIb/IIIa inhibitor, bivalirudin use, radial access, surgical cover, year, vessel of PCI, chronic occlusion, postprocedure TIMI flow, stent type used, rotational atherectomy, laser angioplasty, cutting balloon, side-branch occlusion, and coronary dissection and diagnosis. CI indicates confidence interval; PCI, percutaneous coronary intervention; and TIMI, Thrombolysis in Myocardial Infarction. Adjusted for age, sex, smoking status, body mass index, family history of coronary artery disease, hypercholesterolaemia, hypertension, diabetes mellitus, previous myocardial infarction, previous stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous CABG, left ventricular function, cardiogenic shock, ventilator use, circulatory support, antiplatelet therapy, warfarin, glycoprotein IIb/IIIa inhibitor, bivalirudin use, radial access, surgical cover, year, vessel of PCI, chronic occlusion, postprocedure TIMI (Thrombolysis in Myocardial Infarction) flow, stent type used, rotational atherectomy, laser angioplasty, cutting balloon, side-branch occlusion, coronary dissection, and diagnosis. CABG indicates coronary artery bypass graft; CI, confidence interval; MACE, major adverse cardiac events; and PCI, percutaneous coronary intervention.
times (up to 5 years), the performance of logistic regression models is similar to survival analysis models. 29 
Conclusions
Using data derived from a national PCI database, CP occurred as a PCI procedural complication in 0.33% of cases. Independent predictors of CP included age, female sex, CTO intervention, and atherectomy. CP was strongly associated with poor outcomes.
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